185 related articles for article (PubMed ID: 18424135)
1. Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists.
Melman A; Gao ZG; Kumar D; Wan TC; Gizewski E; Auchampach JA; Jacobson KA
Bioorg Med Chem Lett; 2008 May; 18(9):2813-9. PubMed ID: 18424135
[TBL] [Abstract][Full Text] [Related]
2. (N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.
Tchilibon S; Joshi BV; Kim SK; Duong HT; Gao ZG; Jacobson KA
J Med Chem; 2005 Mar; 48(6):1745-58. PubMed ID: 15771421
[TBL] [Abstract][Full Text] [Related]
3. Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system.
Tosh DK; Chinn M; Ivanov AA; Klutz AM; Gao ZG; Jacobson KA
J Med Chem; 2009 Dec; 52(23):7580-92. PubMed ID: 19499950
[TBL] [Abstract][Full Text] [Related]
4. Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.
Tosh DK; Deflorian F; Phan K; Gao ZG; Wan TC; Gizewski E; Auchampach JA; Jacobson KA
J Med Chem; 2012 May; 55(10):4847-60. PubMed ID: 22559880
[TBL] [Abstract][Full Text] [Related]
5. Selective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system.
Melman A; Wang B; Joshi BV; Gao ZG; Castro Sd; Heller CL; Kim SK; Jeong LS; Jacobson KA
Bioorg Med Chem; 2008 Sep; 16(18):8546-56. PubMed ID: 18752961
[TBL] [Abstract][Full Text] [Related]
6. Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety.
Gao ZG; Joshi BV; Klutz AM; Kim SK; Lee HW; Kim HO; Jeong LS; Jacobson KA
Bioorg Med Chem Lett; 2006 Feb; 16(3):596-601. PubMed ID: 16289820
[TBL] [Abstract][Full Text] [Related]
7. Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.
Jacobson KA; Gao ZG; Tchilibon S; Duong HT; Joshi BV; Sonin D; Liang BT
J Med Chem; 2005 Dec; 48(26):8103-7. PubMed ID: 16366590
[TBL] [Abstract][Full Text] [Related]
8. Partial agonists for A(3) adenosine receptors.
Gao ZG; Jacobson KA
Curr Top Med Chem; 2004; 4(8):855-62. PubMed ID: 15078216
[TBL] [Abstract][Full Text] [Related]
9. Click modification in the N6 region of A3 adenosine receptor-selective carbocyclic nucleosides for dendrimeric tethering that preserves pharmacophore recognition.
Tosh DK; Phan K; Deflorian F; Wei Q; Yoo LS; Gao ZG; Jacobson KA
Bioconjug Chem; 2012 Feb; 23(2):232-47. PubMed ID: 22175234
[TBL] [Abstract][Full Text] [Related]
10. Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary.
Gao ZG; Kim SK; Biadatti T; Chen W; Lee K; Barak D; Kim SG; Johnson CR; Jacobson KA
J Med Chem; 2002 Sep; 45(20):4471-84. PubMed ID: 12238926
[TBL] [Abstract][Full Text] [Related]
11. 2-Dialkynyl derivatives of (N)-methanocarba nucleosides: 'Clickable' A(3) adenosine receptor-selective agonists.
Tosh DK; Chinn M; Yoo LS; Kang DW; Luecke H; Gao ZG; Jacobson KA
Bioorg Med Chem; 2010 Jan; 18(2):508-17. PubMed ID: 20036562
[TBL] [Abstract][Full Text] [Related]
12. 2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists.
Cosyn L; Palaniappan KK; Kim SK; Duong HT; Gao ZG; Jacobson KA; Van Calenbergh S
J Med Chem; 2006 Dec; 49(25):7373-83. PubMed ID: 17149867
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-uronamides as highly potent and selective agonists at the human A3 adenosine receptor.
Jeong LS; Lee HW; Jacobson KA; Kim HO; Shin DH; Lee JA; Gao ZG; Lu C; Duong HT; Gunaga P; Lee SK; Jin DZ; Chun MW; Moon HR
J Med Chem; 2006 Jan; 49(1):273-81. PubMed ID: 16392812
[TBL] [Abstract][Full Text] [Related]
14. Design and in Vivo Characterization of A
Tosh DK; Rao H; Bitant A; Salmaso V; Mannes P; Lieberman DI; Vaughan KL; Mattison JA; Rothwell AC; Auchampach JA; Ciancetta A; Liu N; Cui Z; Gao ZG; Reitman ML; Gavrilova O; Jacobson KA
J Med Chem; 2019 Feb; 62(3):1502-1522. PubMed ID: 30605331
[TBL] [Abstract][Full Text] [Related]
15. Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety.
Gao ZG; Jeong LS; Moon HR; Kim HO; Choi WJ; Shin DH; Elhalem E; Comin MJ; Melman N; Mamedova L; Gross AS; Rodriguez JB; Jacobson KA
Biochem Pharmacol; 2004 Mar; 67(5):893-901. PubMed ID: 15104242
[TBL] [Abstract][Full Text] [Related]
16. A new synthetic route to (North)-methanocarba nucleosides designed as A3 adenosine receptor agonists.
Joshi BV; Moon HR; Fettinger JC; Marquez VE; Jacobson KA
J Org Chem; 2005 Jan; 70(2):439-47. PubMed ID: 15651784
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological characterization of [(125)I]MRS5127, a high affinity, selective agonist radioligand for the A3 adenosine receptor.
Auchampach JA; Gizewski ET; Wan TC; de Castro S; Brown GG; Jacobson KA
Biochem Pharmacol; 2010 Apr; 79(7):967-73. PubMed ID: 19917269
[TBL] [Abstract][Full Text] [Related]
18. Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A
Tosh DK; Salmaso V; Rao H; Bitant A; Fisher CL; Lieberman DI; Vorbrüggen H; Reitman ML; Gavrilova O; Gao ZG; Auchampach JA; Jacobson KA
J Med Chem; 2020 Apr; 63(8):4334-4348. PubMed ID: 32271569
[TBL] [Abstract][Full Text] [Related]
19. Truncated Nucleosides as A(3) Adenosine Receptor Ligands: Combined 2-Arylethynyl and Bicyclohexane Substitutions.
Tosh DK; Paoletta S; Phan K; Gao ZG; Jacobson KA
ACS Med Chem Lett; 2012 Jul; 3(7):596-601. PubMed ID: 23145215
[TBL] [Abstract][Full Text] [Related]
20. Ring-Constrained (N)-methanocarba nucleosides as adenosine receptor agonists: independent 5'-uronamide and 2'-deoxy modifications.
Lee K; Ravi G; Ji XD; Marquez VE; Jacobson KA
Bioorg Med Chem Lett; 2001 May; 11(10):1333-7. PubMed ID: 11392549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
